References

  1. Cloud, J. (2010). Why Your DNA Insn't Your Destiny. Time Magazine 172.
  2. Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., Ge, Y., Gunawardena, J., Hendrickson, R. C., Hergenrother, P. J., Huber, C. G., Ivanov, A. R., Jensen, O. N., Jewett, M. C., Kelleher, N. L., Kiessling, L. L., Krogan, N. J., Larsen, M. R., Loo, J. A., Ogorzalek Loo, R. R., Lundberg, E., MacCoss, M. J., Mallick, P., Mootha, V. K., Mrksich, M., Muir, T. W., Patrie, S. M., Pesavento, J. J., Pitteri, S. J., Rodriguez, H., Saghatelian, A., Sandoval, W., Schluter, H., Sechi, S., Slavoff, S. A., Smith, L. M., Snyder, M. P., Thomas, P. M., Uhlen, M., Van Eyk, J. E., Vidal, M., Walt, D. R., White, F. M., Williams, E. R., Wohlschlager, T., Wysocki, V. H., Yates, N. A., Young, N. L. & Zhang, B. (2018). How many human proteoforms are there? Nat Chem Biol 14, 206-214.
  3. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J. P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Muller, S., Pawson, T., Gingras, A. C., Arrowsmith, C. H. & Knapp, S. (2012). Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214-31.
  4. Lubula, M. Y., Eckenroth, B. E., Carlson, S., Poplawski, A., Chruszcz, M. & Glass, K. C. (2014). Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain. FEBS Lett.
  5. Poplawski, A., Hu, K., Lee, W., Natesan, S., Peng, D., Carlson, S., Shi, X., Balaz, S., Markley, J. L. & Glass, K. C. (2014). Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain. J Mol Biol 426, 1661-76.
  6. Kitabayashi, I., Aikawa, Y., Yokoyama, A., Hosoda, F., Nagai, M., Kakazu, N., Abe, T. & Ohki, M. (2001). Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia 15, 89-94.
  7. Carapeti, M., Aguiar, R. C., Goldman, J. M. & Cross, N. C. (1998). A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91, 3127-33.
  8. Champagne, K. S., Saksouk, N., Pena, P. V., Johnson, K., Ullah, M., Yang, X. J., Cote, J. & Kutateladze, T. G. (2008). The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide. Proteins 72, 1371-6.
  9. Lalonde, M. E., Avvakumov, N., Glass, K. C., Joncas, F. H., Saksouk, N., Holliday, M., Paquet, E., Yan, K., Tong, Q., Klein, B. J., Tan, S., Yang, X. J., Kutateladze, T. G. & Cote, J. (2013). Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity. Genes Dev 27, 2009-24.
  10. Carlson, S. & Glass, K. C. (2014). The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease. J Cell Physiol.
  11. Filippakopoulos, P. & Knapp, S. (2014). Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov 13, 337-56